Globus Medical, Inc. (BMV:GMED)
1,067.00
-13.00 (-1.20%)
At close: Oct 2, 2025
Globus Medical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2011 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2011 - 2019 |
Cash & Equivalents | 229.45 | 784.44 | 467.29 | 150.47 | 193.07 | 239.4 | Upgrade |
Short-Term Investments | - | 105.62 | 50.5 | 295.59 | 250.38 | 187.34 | Upgrade |
Cash & Short-Term Investments | 229.45 | 890.06 | 517.79 | 446.06 | 443.45 | 426.74 | Upgrade |
Cash Growth | -53.45% | 71.90% | 16.08% | 0.59% | 3.91% | 37.00% | Upgrade |
Accounts Receivable | 611.57 | 557.7 | 503.24 | 213.25 | 164.44 | 141.68 | Upgrade |
Other Receivables | 48.56 | 20.63 | 1.64 | 4.06 | 1.22 | 6.42 | Upgrade |
Total Trade Receivables | 660.12 | 578.33 | 504.87 | 217.31 | 165.65 | 148.1 | Upgrade |
Inventory | 772.13 | 659.23 | 848.14 | 298.98 | 237 | 229.15 | Upgrade |
Other Current Assets | 68.2 | 49.64 | 44.58 | 21 | 18.42 | 17.77 | Upgrade |
Total Current Assets | 1,730 | 2,177 | 1,915 | 983.34 | 864.52 | 821.77 | Upgrade |
Net Property, Plant & Equipment | 649.09 | 611.56 | 646.86 | 249.72 | 221.08 | 216.88 | Upgrade |
Other Intangible Assets | 796.37 | 795.12 | 924.6 | 63.57 | 68.66 | 86.95 | Upgrade |
Goodwill | 1,435 | 1,432 | 1,435 | 197.47 | 179.71 | 156.72 | Upgrade |
Long-Term Investments | - | 66.13 | 75.43 | 495.85 | 562.48 | 358.52 | Upgrade |
Other Long-Term Assets | 350.74 | 169.3 | 89.28 | 86.17 | 60.83 | 38.65 | Upgrade |
Total Assets | 4,961 | 5,252 | 5,086 | 2,076 | 1,957 | 1,679 | Upgrade |
Accounts Payable | 87.1 | 75.12 | 56.67 | 36.1 | 21.96 | 18.21 | Upgrade |
Accrued Expenses | 281.75 | 260.59 | 240.46 | 92.17 | 91.17 | 78.33 | Upgrade |
Current Portion of Long-Term Debt | - | 443.35 | - | - | - | - | Upgrade |
Current Portion of Leases | 13.18 | 10.25 | 11.97 | 2.54 | - | - | Upgrade |
Unearned Revenue | 24.02 | 22.14 | 18.37 | 14.1 | 12.03 | 8.13 | Upgrade |
Other Current Liabilities | 18.62 | 44.46 | 64.88 | 14.3 | 15.02 | 16.13 | Upgrade |
Total Current Liabilities | 424.66 | 855.91 | 392.35 | 159.2 | 140.16 | 120.79 | Upgrade |
Long-Term Debt | - | - | 417.4 | - | - | - | Upgrade |
Long-Term Leases | 107.93 | 83.59 | 91.04 | 3.48 | - | - | Upgrade |
Other Long-Term Liabilities | 132.82 | 134.92 | 187.34 | 67.07 | 75.71 | 52.4 | Upgrade |
Total Long-Term Liabilities | 240.74 | 218.5 | 695.78 | 70.55 | 75.71 | 52.4 | Upgrade |
Total Liabilities | 665.41 | 1,074 | 1,088 | 229.75 | 215.88 | 173.19 | Upgrade |
Common Stock | 0.14 | 0.14 | 0.14 | 0.1 | 0.1 | 0.1 | Upgrade |
Additional Paid-in Capital | 3,072 | 3,031 | 2,871 | 630.95 | 553.79 | 457.16 | Upgrade |
Accumulated Other Comprehensive Income | 10.24 | -6.86 | -10.19 | -24.63 | -6.77 | 3.96 | Upgrade |
Retained Earnings | 1,214 | 1,153 | 1,137 | 1,240 | 1,194 | 1,045 | Upgrade |
Shareholders' Equity | 4,296 | 4,177 | 3,998 | 1,846 | 1,741 | 1,506 | Upgrade |
Total Liabilities & Equity | 4,961 | 5,252 | 5,086 | 2,076 | 1,957 | 1,679 | Upgrade |
Total Debt | 121.1 | 537.19 | 520.4 | 6.01 | 0 | 0 | Upgrade |
Net Cash (Debt) | 108.34 | 352.87 | -2.62 | 440.05 | 443.45 | 426.74 | Upgrade |
Net Cash Growth | -69.30% | - | - | -0.77% | 3.91% | 37.00% | Upgrade |
Net Cash Per Share | 0.78 | 2.56 | -0.02 | 4.29 | 4.28 | 4.23 | Upgrade |
Book Value | 4,296 | 4,177 | 3,998 | 1,846 | 1,741 | 1,506 | Upgrade |
Book Value Per Share | 31.01 | 30.30 | 34.88 | 17.99 | 16.81 | 14.92 | Upgrade |
Tangible Book Value | 2,064 | 1,950 | 1,639 | 1,585 | 1,493 | 1,263 | Upgrade |
Tangible Book Value Per Share | 14.90 | 14.14 | 14.30 | 15.45 | 14.41 | 12.50 | Upgrade |
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.